Annals of Oncology 14:191-196, 2003
© 2003 European Society for Medical Oncology
Review Article |
The unknown biology of the unknown primary tumour: a literature review
1 Department of Internal Medicine, Slingeland Hospital Doetinchem, Doetinchem; 2 Department of Internal Medicine, University Hospital Maastricht, Maastricht; 3 Department of Molecular Cell Biology, Growth & Development Research Institute, University of Maastricht, Maastricht, The Netherlands
Received 12 June 2002; revised 4 September 2002; accepted 17 September 2002
Abstract
The unknown primary tumour (UPT) is an intriguing clinical phenomenon found in approximately 5% of all newly diagnosed patients with cancer. It is unclear whether UPT forms a distinct biological entity with specific genetic and phenotypic characteristics, or whether it is merely a clinical presentation of metastases in patients in whom the primary tumour cannot be detected and does not result in any visible clinical signs. Understanding the basic biology of UPT may shed light on this issue and, moreover, may have a direct impact on clinical care. A review of the literature revealed only a limited number of publications describing the genetic and phenotypic features of UPT, most of which focus only on the potential of these markers to predict prognosis. The question as to whether the biology of UPT is different from tumours of known primaries therefore remains unanswered. Further insight into the molecular mechanisms underlying the oncogenesis of UPT, e.g. by applying newly available DNA and gene profiling microarray techniques, will be necessary to understand its specific biology and to develop more effective treatments.
Key words: biology, review, unknown primary tumour
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. S. Saad, N. Ismiil, V. Dube, S. Nofech-Mozes, and M. A. Khalifa CDX-2 Expression Is a Common Event in Primary Intestinal-type Endocervical Adenocarcinoma Am J Clin Pathol, October 1, 2009; 132(4): 531 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cheng, P. Liu, Z. C. Wang, L. Zou, S. Santiago, V. Garbitt, O. V. Gjoerup, J. D. Iglehart, A. Miron, A. L. Richardson, et al. SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis Sci. Signal., July 21, 2009; 2(80): ra35 - ra35. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pentheroudakis, E. Briasoulis, and N. Pavlidis Cancer of Unknown Primary Site: Missing Primary or Missing Biology? Oncologist, April 1, 2007; 12(4): 418 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Manjarrez, R. Ocadiz, L. Valle, C. Pacheco, A. Marroquin, C. De la Torre, M. Selman, and P. Gariglio Detection of Human Papillomavirus and Relevant Tumor Suppressors and Oncoproteins in Laryngeal Tumors Clin. Cancer Res., December 1, 2006; 12(23): 6946 - 6951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Talbot, C. Estilo, E. Maghami, I. S. Sarkaria, D. K. Pham, P. O-charoenrat, N. D. Socci, I. Ngai, D. Carlson, R. Ghossein, et al. Gene Expression Profiling Allows Distinction between Primary and Metastatic Squamous Cell Carcinomas in the Lung Cancer Res., April 15, 2005; 65(8): 3063 - 3071. [Abstract] [Full Text] [PDF] |
||||




